ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

イタリアでの小児腫瘍科費用について今すぐご確認ください

料金はお問い合わせください
イタリアトルコオーストリア
骨髄移植術から $95,000から $36,000から $140,000
骨切除術から $18,000から $8,000から $25,000
非血縁者間同種骨髄移植術から $150,000から $80,000から $180,000
自家骨髄移植術から $90,000から $31,500から $50,000
脳腫瘍摘出術から $40,000から $19,710から $60,000
データは2026年May月時点でBookimedにより検証され、世界7件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

すべての小児腫瘍科疾患

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは小児腫瘍科治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。小児腫瘍科治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。小児腫瘍科治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

イタリアの最高の小児腫瘍科クリニックをご発見ください:7件の認証済み選択肢と料金

クリニックはBookimedのスマートシステムにより、5つの主要基準でのデータサイエンス分析を使用してランク付けされています。
San Donato Hospital
San Raffaele
IRCCS OSPEDALE GALEAZZI - SANT'AMBROGIO
Ospedale San Carlo di Nancy
Maria Cecilia Hospital

イタリアのトップ小児腫瘍科センター

  • San Donato Hospital, イタリア
  • San Raffaele, イタリア
  • IRCCS OSPEDALE GALEAZZI - SANT'AMBROGIO , イタリア
  • Ospedale San Carlo di Nancy, イタリア
  • Maria Cecilia Hospital, イタリア

イタリアでの医学評価を受ける:その分野の最高の専門医をお選びください

すべての医師を見る

このコンテンツを共有

Bookimed患者のビデオストーリー

Dayana
I combined my vacation in Antalya with a check-up.
治療: 女性検査
クリニック: Memorial Antalya Hospital
Igor
It was great! Transfers, accommodation, treatment—all included.
治療: 歯科インプラント
クリニック: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
治療: 女性検査
クリニック: Severance Hospital
更新済み: 10/20/2022
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

イタリアでの小児腫瘍科に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What are the top-rated pediatric oncology hospitals in Italy?

Italy hosts globally recognized pediatric oncology centers specializing in advanced gene therapy and hematopoietic treatments. Top-rated facilities include San Raffaele in Milan, which pioneered the world's first stem cell therapy for ADA-SCID. These centers combine intensive research with clinical care under IRCCS accreditation.

  • Clinical expertise: San Raffaele performs 52,000+ operations annually with specialized pediatric immunohematology units.
  • Specialized doctors: Prof. Dr. Alessandro Aiuti at San Raffaele leads research in Wiskott-Aldrich Syndrome.
  • Advanced certifications: Leading hospitals maintain IRCCS status, signifying excellence in clinical research and assistance.
  • High-volume care: IRCCS Ospedale Galeazzi - Sant'Ambrogio serves 343,500+ patients yearly with ISO-certified safety standards.

Bookimed Expert Insight: Data shows a strong correlation between research activity and patient outcomes in Milan. IRCCS-accredited clinics like San Raffaele integrate lab research directly into bedside care. This structure allows pediatric patients to access experimental gene therapies not available in standard regional hospitals.

Patient Consensus: Parents note that traveling to northern specialized centers is often necessary for complex cases requiring multidisciplinary teams. Families emphasize checking for English-speaking staff to reduce stress during long-term treatment protocols.

Is there a national network that guarantees standardised childhood cancer care across Italy?

Italy uses the Italian Association of Pediatric Hematology and Oncology (AIEOP) to standardize childhood cancer care. This network includes 50 specialized centers following unified diagnostic protocols. While AIEOP coordinates clinical trials and treatment standards, regional resource disparities persist between Northern and Southern Italy.

  • National network: AIEOP coordinates research and standardized therapy protocols across 50 Italian centers.
  • Member clinics: Top research hospitals like San Raffaele in Milan participate in advanced trials.
  • Regional access: Over 16% of patients travel across regions to access specialized northern hubs.
  • Advanced therapies: San Raffaele offers unique gene therapies for rare conditions like ADA-SCID.

Bookimed Expert Insight: Quality of care in Italy often correlates with a clinic's research status. Hospitals like San Raffaele are designated as IRCCS, meaning they must legally combine clinical care with active scientific research. Data shows these institutions handle over 300,000 patients annually. Choosing an IRCCS facility typically ensures access to the latest international protocols before they reach general local hospitals.

Patient Consensus: Parents note that while protocols are technically standardized, the speed of diagnosis and access to newer technology vary by region. Many families recommend seeking a second opinion at a major northern hub if your local hospital lacks specialized pediatric oncology infrastructure.

Are current clinical trials available for difficult-to-treat pediatric cancers in Italy?

Italy offers active clinical trials for difficult-to-treat pediatric cancers including high-risk neuroblastoma and relapsed leukemia. Specialized centers like San Raffaele in Milan conduct advanced research in gene therapy. These programs follow European protocols to provide innovative treatments for refractory and rare pediatric cases.

  • Clinic credentials: San Raffaele holds IRCCS accreditation from the Italian Ministry of Health.
  • Specialized units: Dr. Alessandro Aiuti leads gene therapy trials for pediatric patients.
  • CAR-T availability: Phase 2 trials for relapsed B-ALL are recruiting in Rome.
  • Research scope: Italian centers lead trials for Wiskott-Aldrich Syndrome and neuroblastoma.

Bookimed Expert Insight: Clinics with IRCCS status, like San Raffaele, integrate research directly into patient care. This status is only granted to few institutions by the Italian Ministry of Health. Patients at these centers often gain faster access to gene therapy and stem cell protocols. This link between research and clinic ensures updated treatment standards for rare conditions.

Patient Consensus: Patients note it is vital to contact AIEOP-affiliated hospitals directly with pathology reports. Many families emphasize preparing for regional travel as specific trial slots for difficult cases fill quickly.

What long-term survival follow-up programs are offered after treatment ends?

Pediatric oncology follow-up in Italy transitions children from active treatment to long-term wellness monitoring. Programs focus on recurrence detection, managing late effects, and psychosocial support. Specialized centers like San Raffaele in Milan provide systematic screenings. These include cardiac imaging, endocrine assessments, and personalized survivorship plans.

  • Recurrence monitoring: Regular blood tests and imaging help detect signs of cancer returning early.
  • Late effects care: Specialized monitoring addresses heart issues, thyroid function, and cognitive development changes.
  • Rehabilitation services: Physical and occupational therapies help restore daily function and physical strength.
  • Psychosocial support: Counseling services manage anxiety and help children reintegrate into school and peer groups.

Bookimed Expert Insight: Italian research hospitals like San Raffaele often lead in specialized follow-up due to high surgical volumes. They perform over 52,000 operations annually. This experience allows doctors like Dr. Alessandro Aiuti to create precise monitoring protocols for rare conditions. Families should prioritize centers with IRCCS accreditation for the most standardized survivorship data.

Patient Consensus: Parents note that getting a written treatment summary is vital for future health. They often find that Northern Italian centers offer more organized coordination with local pediatricians than other regions.

Can parents stay overnight with their child during hospitalization and treatment?

Most Italian pediatric oncology centers allow one parent to stay overnight with their child. This practice supports family-centered care and significantly reduces patient anxiety during intensive treatments. Facilities like San Raffaele provide bedside cots or pull-out beds for a parent to remain present 24/7.

  • Bedside accommodation: In-room cots or sleeper chairs are standard in pediatric oncology units.
  • Parental meals: Many top Italian hospitals provide complimentary dinner for the accompanying parent.
  • Shift flexibility: Parents can often rotate shifts to manage fatigue during long hospitalizations.
  • Facility access: Standard wards include access to on-site showers and laundry for parents.

Bookimed Expert Insight: Italian research hospitals with IRCCS accreditation, such as San Raffaele, integrate clinical care with advanced research. Our data indicates these centers prioritize rooming-in specifically for complex cases like gene therapy. This ensures parents are present for medical rounds and immediate post-procedure monitoring.

Patient Consensus: Parents note that having a bed right next to their child makes a huge difference during chemotherapy. They suggest bringing a personal pillow since hospital cots are often quite basic.

無料相談を受ける

最適な連絡方法をお選びください